Panagora Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.9M Buy
129,055
+118,375
+1,108% +$43.9M 0.15% 132
2026
Q1
$3.13M Sell
10,680
-133,233
-93% -$43.8M 0.01% 504
2025
Q4
$50.4M Sell
143,913
-26,931
-16% -$9.1M 0.18% 123
2025
Q3
$55.2M Buy
170,844
+127,625
+295% +$39.7M 0.22% 103
2025
Q2
$16.8M Sell
43,219
-4,240
-9% -$1.71M 0.08% 207
2025
Q1
$20.6M Buy
47,459
+41,707
+725% +$16.7M 0.1% 174
2024
Q4
$2.12M Sell
5,752
-57,824
-91% -$24.2M 0.01% 502
2024
Q3
$33.1M Sell
63,576
-178,701
-74% -$95.5M 0.16% 129
2024
Q2
$131M Buy
242,277
+134,281
+124% +$71M 0.66% 32
2024
Q1
$56M Buy
107,996
+23,447
+28% +$11.7M 0.29% 85
2023
Q4
$39.9M Sell
84,549
-108,248
-56% -$50.1M 0.22% 108
2023
Q3
$83.9M Sell
192,797
-928
-0.5% -$421K 0.52% 50
2023
Q2
$86.1M Buy
193,725
+39,465
+26% +$18.2M 0.51% 48
2023
Q1
$70.9M Sell
154,260
-67,941
-31% -$32.3M 0.45% 56
2022
Q4
$114M Buy
222,201
+52,385
+31% +$26.6M 0.75% 18
2022
Q3
$77.1M Sell
169,816
-2,573
-1% -$1.23M 0.53% 35
2022
Q2
$83.2M Sell
172,389
-10,536
-6% -$5.21M 0.55% 33
2022
Q1
$89.9M Sell
182,925
-517
-0.3% -$236K 0.49% 38
2021
Q4
$85M Buy
183,442
+121,744
+197% +$51.2M 0.45% 45
2021
Q3
$23M Buy
61,698
+15,367
+33% +$5.84M 0.12% 168
2021
Q2
$17.7M Buy
46,331
+631
+1% +$241K 0.09% 208
2021
Q1
$16.4M Buy
45,700
+11,820
+35% +$3.8M 0.09% 211
2020
Q4
$10.9M Sell
33,880
-3,895
-10% -$1.2M 0.06% 264
2020
Q3
$10.1M Sell
37,775
-4,747
-11% -$1.28M 0.06% 250
2020
Q2
$11.2M Sell
42,522
-576
-1% -$154K 0.07% 241
2020
Q1
$9.79M Sell
43,098
-22,078
-34% -$6.02M 0.07% 230
2019
Q4
$19.7M Buy
65,176
+46,724
+253% +$12.9M 0.09% 229
2019
Q3
$4.43M Buy
18,452
+4,315
+31% +$1.18M 0.02% 493
2019
Q2
$3.99M Buy
14,137
+19
+0.1% +$5.19K 0.02% 564
2019
Q1
$4.05M Sell
14,118
-814
-5% -$235K 0.02% 575
2018
Q4
$3.92M Buy
14,932
+2,530
+20% +$696K 0.02% 540
2018
Q3
$3.4M Sell
12,402
-11,307
-48% -$2.94M 0.01% 648
2018
Q2
$5.64M Sell
23,709
-99,066
-81% -$22.9M 0.02% 491
2018
Q1
$27M Sell
122,775
-70,708
-37% -$16.6M 0.11% 186
2017
Q4
$43.5M Sell
193,483
-23,354
-11% -$4.97M 0.16% 144
2017
Q3
$41.2M Sell
216,837
-268,130
-55% -$51M 0.16% 142
2017
Q2
$91.2M Buy
484,967
+30,831
+7% +$5.54M 0.37% 63
2017
Q1
$75.1M Buy
454,136
+128,303
+39% +$20.4M 0.31% 68
2016
Q4
$46.8M Sell
325,833
-121,929
-27% -$16.3M 0.21% 111
2016
Q3
$56.1M Sell
447,762
-290,454
-39% -$37.5M 0.27% 85
2016
Q2
$97M Sell
738,216
-67,660
-8% -$9.26M 0.48% 48
2016
Q1
$112M Buy
805,876
+43,632
+6% +$5.83M 0.56% 35
2015
Q4
$106M Sell
762,244
-22,958
-3% -$3.16M 0.52% 42
2015
Q3
$110M Buy
785,202
+73,915
+10% +$11.1M 0.58% 35
2015
Q2
$117M Sell
711,287
-67,427
-9% -$10.8M 0.59% 34
2015
Q1
$120M Buy
778,714
+9,844
+1% +$1.4M 0.61% 33
2014
Q4
$96.6M Buy
768,870
+105,945
+16% +$13.1M 0.49% 45
2014
Q3
$79.3M Buy
662,925
+102,687
+18% +$11.8M 0.38% 69
2014
Q2
$60.3M Buy
560,238
+37,935
+7% +$3.91M 0.29% 86
2014
Q1
$52M Buy
522,303
+6,055
+1% +$548K 0.25% 108
2013
Q4
$47.7M Buy
516,248
+196,149
+61% +$17.4M 0.22% 107
2013
Q3
$26.8M Buy
320,099
+58,471
+22% +$5.01M 0.13% 152
2013
Q2
$21.4M Buy
+261,628
New +$19.6M 0.11% 178

Other funds holding ELV

Panagora Asset Management's ELV Position: Q2 2026 in Review

Panagora Asset Management increased its Elevance Health (ELV) stake by 1,108% in Q2 2026, buying an estimated $43.9M and bringing the position to 129,055 shares worth $49.9M. The position accounts for 0.15% of the portfolio, ranked #132.

Panagora Asset Management first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $131M in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Panagora Asset Management held 129,055 shares of Elevance Health worth $49.9M as of Q2 2026.
  • Panagora Asset Management bought 118,375 Elevance Health shares in Q2 2026, an estimated $43.9M.
  • Elevance Health made up 0.15% of Panagora Asset Management's portfolio in Q2 2026, its #132 holding.
  • Panagora Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • Panagora Asset Management's Elevance Health position peaked at $131M in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.